Abstract The coronavirus disease 2019 (COVID-19) pandemic has had a major global
impact on solid organ transplantation (SOT). An estimated 16% global reduction in …

Background Liver diseases post-COVID-19 vaccination is extremely rare but can occur. A
growing body of evidence has indicated that portal vein thrombosis, autoimmune hepatitis …

SARS-CoV-2 infection is known to lead to severe morbidity and mortality in patients with
liver cirrhosis. For this reason, vaccination of these patients against COVID-19 is widely …

Background and aims Chronic liver disease (CLD) patients and liver transplant (LT)
recipients have an increased risk of morbidity and mortality from coronavirus disease 2019 …

The antibody and T cell responses after SARS-CoV-2 vaccination have not been formally
compared between kidney and liver transplant recipients. Using a multiplex assay, we …

End-stage liver disease patients undergoing liver transplantation are prone to develop
numerous infectious complications because of immunosuppression, surgical interventions …

Various vaccines against severe acute respiratory syndrome coronavirus 2 have been
developed in response to the coronavirus disease 2019 (COVID-19) global pandemic …

Coronavirus-disease-2019 (COVID-19) mRNA vaccination effectively reduces mortality and
morbidity in cirrhotic patients, but the immunogenicity and safety of vaccination have been …

Background Vaccine nonresponse during the coronavirus disease 2019 (COVID-19)
pandemic has considerable individual and societal risks. Objective To investigate the …

Background: SARS-CoV-2 vaccination induces a varied immune response among persons
with chronic liver disease (CLD) and solid organ transplant recipients (SOTRs). We aimed to …